CTOs on the Move

Revolution Enterprises

www.revolutionenterprises.org

 
Revolution Cannabis is committed to producing the cleanest, most reliable and efficacious medical cannabis products. Our team is comprised of passionate cannabis cultivation, public health, and research professionals united by a desire to cultivate health and happiness through the science of cannabis. Revolution`s core values permeate every facet of operations spanning cultivation, breeding, production, packaging, labeling, community outreach, and more.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

E-T Endodontic Technology

E-T Endodontic Technology Ltd is a Halifax, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dental Services Group

We are a growing network of dental laboratories based in North America, providing dentists with the best of both worlds: the personal relationship and care of a local laboratory, combined with the technical expertise and full suite of offerings of a national laboratory.

Space Maintainers Laboratory

Space Maintainers Laboratory is a Chatsworth, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tempo Wholesale Medical

Tempo Wholesale Medical Llc is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lucira Health

Lucira Health has developed an at home COVID-19 test kit that delivers PCR quality molecular accuracy in the palm of your hand in 30 minutes or less. Our technology is transforming how we reduce the spread of infectious diseases by bringing accurate, easy-to-use self-testing into the home. This home test kit has not been FDA cleared or approved. This home test kit has been authorized by FDA under EUA. This home test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This home test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or revoked sooner.